

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.37520781 |
| 2 | oxidative phosphorylation (GO:0006119) | 5.05008173 |
| 3 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.04647623 |
| 4 | respiratory electron transport chain (GO:0022904) | 5.02836738 |
| 5 | electron transport chain (GO:0022900) | 4.96413204 |
| 6 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.89035626 |
| 7 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.88013733 |
| 8 | protein complex biogenesis (GO:0070271) | 4.70022199 |
| 9 | tricarboxylic acid cycle (GO:0006099) | 4.68635534 |
| 10 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.66467349 |
| 11 | ATP synthesis coupled proton transport (GO:0015986) | 4.66467349 |
| 12 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.58651689 |
| 13 | NADH dehydrogenase complex assembly (GO:0010257) | 4.58651689 |
| 14 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.58651689 |
| 15 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.46938644 |
| 16 | ribosomal small subunit assembly (GO:0000028) | 4.45165248 |
| 17 | daunorubicin metabolic process (GO:0044597) | 4.42103313 |
| 18 | polyketide metabolic process (GO:0030638) | 4.42103313 |
| 19 | doxorubicin metabolic process (GO:0044598) | 4.42103313 |
| 20 | regulation of cofactor metabolic process (GO:0051193) | 4.37126687 |
| 21 | regulation of coenzyme metabolic process (GO:0051196) | 4.37126687 |
| 22 | aerobic respiration (GO:0009060) | 4.22593379 |
| 23 | inner mitochondrial membrane organization (GO:0007007) | 4.18158563 |
| 24 | platelet dense granule organization (GO:0060155) | 4.15980429 |
| 25 | muscle filament sliding (GO:0030049) | 4.14216573 |
| 26 | actin-myosin filament sliding (GO:0033275) | 4.14216573 |
| 27 | respiratory chain complex IV assembly (GO:0008535) | 4.07580498 |
| 28 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.96373825 |
| 29 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.95714566 |
| 30 | branched-chain amino acid catabolic process (GO:0009083) | 3.94999221 |
| 31 | creatine metabolic process (GO:0006600) | 3.89539881 |
| 32 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.76525772 |
| 33 | succinate metabolic process (GO:0006105) | 3.75534235 |
| 34 | DNA deamination (GO:0045006) | 3.69167118 |
| 35 | oxaloacetate metabolic process (GO:0006107) | 3.68238238 |
| 36 | regulation of skeletal muscle contraction (GO:0014819) | 3.67012527 |
| 37 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.66329476 |
| 38 | regulation of sulfur metabolic process (GO:0042762) | 3.66296544 |
| 39 | NADH metabolic process (GO:0006734) | 3.64929109 |
| 40 | branched-chain amino acid metabolic process (GO:0009081) | 3.64124558 |
| 41 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.63210456 |
| 42 | response to interferon-beta (GO:0035456) | 3.62804928 |
| 43 | cytochrome complex assembly (GO:0017004) | 3.55698362 |
| 44 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.53092850 |
| 45 | definitive hemopoiesis (GO:0060216) | 3.52743208 |
| 46 | metallo-sulfur cluster assembly (GO:0031163) | 3.49116973 |
| 47 | iron-sulfur cluster assembly (GO:0016226) | 3.49116973 |
| 48 | regulation of oxidative phosphorylation (GO:0002082) | 3.48717143 |
| 49 | valine metabolic process (GO:0006573) | 3.47587436 |
| 50 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 3.44049381 |
| 51 | substrate-independent telencephalic tangential migration (GO:0021826) | 3.44049381 |
| 52 | regulation of membrane repolarization (GO:0060306) | 3.43410127 |
| 53 | actin-mediated cell contraction (GO:0070252) | 3.39864197 |
| 54 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.37582965 |
| 55 | phospholipid scrambling (GO:0017121) | 3.33870527 |
| 56 | positive regulation of respiratory burst (GO:0060267) | 3.31169660 |
| 57 | proteasome assembly (GO:0043248) | 3.26641880 |
| 58 | myofibril assembly (GO:0030239) | 3.24312698 |
| 59 | sarcomere organization (GO:0045214) | 3.23806659 |
| 60 | ubiquinone biosynthetic process (GO:0006744) | 3.21979735 |
| 61 | quinone biosynthetic process (GO:1901663) | 3.21979735 |
| 62 | cardiac myofibril assembly (GO:0055003) | 3.21142730 |
| 63 | cardiac muscle contraction (GO:0060048) | 3.18138370 |
| 64 | cellular respiration (GO:0045333) | 3.17233963 |
| 65 | purine-containing compound salvage (GO:0043101) | 3.16986629 |
| 66 | fatty acid beta-oxidation (GO:0006635) | 3.14643429 |
| 67 | dopamine transport (GO:0015872) | 3.14221202 |
| 68 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.10131961 |
| 69 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.07959928 |
| 70 | ATP biosynthetic process (GO:0006754) | 3.07525951 |
| 71 | purine nucleotide salvage (GO:0032261) | 3.05796562 |
| 72 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.05724425 |
| 73 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.04983218 |
| 74 | 2-oxoglutarate metabolic process (GO:0006103) | 3.04663307 |
| 75 | mannosylation (GO:0097502) | 3.02931199 |
| 76 | L-methionine salvage (GO:0071267) | 3.00895107 |
| 77 | L-methionine biosynthetic process (GO:0071265) | 3.00895107 |
| 78 | amino acid salvage (GO:0043102) | 3.00895107 |
| 79 | regulation of cellular respiration (GO:0043457) | 3.00749494 |
| 80 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.00524150 |
| 81 | oxygen transport (GO:0015671) | 3.00233998 |
| 82 | regulation of relaxation of muscle (GO:1901077) | 2.99817117 |
| 83 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.97976579 |
| 84 | fatty acid catabolic process (GO:0009062) | 2.97922827 |
| 85 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.97003274 |
| 86 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.95548822 |
| 87 | mitochondrion transport along microtubule (GO:0047497) | 2.95548822 |
| 88 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.95458931 |
| 89 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.95458931 |
| 90 | establishment of mitochondrion localization (GO:0051654) | 2.93773578 |
| 91 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.91973558 |
| 92 | GDP-mannose metabolic process (GO:0019673) | 2.90665999 |
| 93 | short-term memory (GO:0007614) | 2.90636037 |
| 94 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.89679405 |
| 95 | L-phenylalanine catabolic process (GO:0006559) | 2.89679405 |
| 96 | heart contraction (GO:0060047) | 2.89232098 |
| 97 | heart process (GO:0003015) | 2.89232098 |
| 98 | mast cell activation (GO:0045576) | 2.88778702 |
| 99 | lysine metabolic process (GO:0006553) | 2.88155984 |
| 100 | lysine catabolic process (GO:0006554) | 2.88155984 |
| 101 | cellular ketone body metabolic process (GO:0046950) | 2.86805273 |
| 102 | termination of RNA polymerase III transcription (GO:0006386) | 2.85789368 |
| 103 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.85789368 |
| 104 | striated muscle contraction (GO:0006941) | 2.85771518 |
| 105 | L-phenylalanine metabolic process (GO:0006558) | 2.84144630 |
| 106 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.84144630 |
| 107 | response to misfolded protein (GO:0051788) | 2.83370719 |
| 108 | glyoxylate metabolic process (GO:0046487) | 2.83115246 |
| 109 | neuronal action potential propagation (GO:0019227) | 2.82924780 |
| 110 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.82599564 |
| 111 | mast cell degranulation (GO:0043303) | 2.80943116 |
| 112 | mast cell activation involved in immune response (GO:0002279) | 2.80943116 |
| 113 | neuronal ion channel clustering (GO:0045161) | 2.78171682 |
| 114 | pattern specification involved in kidney development (GO:0061004) | 2.77665074 |
| 115 | translational termination (GO:0006415) | 2.76087901 |
| 116 | lipid oxidation (GO:0034440) | 2.75145369 |
| 117 | fatty acid oxidation (GO:0019395) | 2.74526269 |
| 118 | negative regulation of response to food (GO:0032096) | 2.69934509 |
| 119 | negative regulation of appetite (GO:0032099) | 2.69934509 |
| 120 | AMP metabolic process (GO:0046033) | 2.69168243 |
| 121 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.68671776 |
| 122 | adenosine metabolic process (GO:0046085) | 2.67552939 |
| 123 | axonal fasciculation (GO:0007413) | 2.65934990 |
| 124 | viral transcription (GO:0019083) | 2.65889981 |
| 125 | aspartate family amino acid catabolic process (GO:0009068) | 2.65822215 |
| 126 | respiratory system process (GO:0003016) | 2.65358139 |
| 127 | pseudouridine synthesis (GO:0001522) | 2.64475986 |
| 128 | arginine catabolic process (GO:0006527) | 2.64281247 |
| 129 | segment specification (GO:0007379) | 2.63857037 |
| 130 | ubiquinone metabolic process (GO:0006743) | 2.62769138 |
| 131 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.62463879 |
| 132 | regulation of cell communication by electrical coupling (GO:0010649) | 2.60984311 |
| 133 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 2.60267666 |
| 134 | GTP biosynthetic process (GO:0006183) | 2.60173905 |
| 135 | quinone metabolic process (GO:1901661) | 2.59140376 |
| 136 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.59139990 |
| 137 | tricarboxylic acid metabolic process (GO:0072350) | 2.57754508 |
| 138 | regulation of mitochondrial translation (GO:0070129) | 2.57239928 |
| 139 | membrane repolarization (GO:0086009) | 2.57157819 |
| 140 | somite development (GO:0061053) | 2.55301712 |
| 141 | catecholamine transport (GO:0051937) | 2.54671254 |
| 142 | chaperone-mediated protein transport (GO:0072321) | 2.53271836 |
| 143 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.51820912 |
| 144 | ribosomal small subunit biogenesis (GO:0042274) | 2.51265785 |
| 145 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 2.50995867 |
| 146 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 2.50995867 |
| 147 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.50889708 |
| 148 | behavioral response to nicotine (GO:0035095) | 2.50451739 |
| 149 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.48217144 |
| 150 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.47187941 |
| 151 | monocarboxylic acid catabolic process (GO:0072329) | 2.46900322 |
| 152 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.46884939 |
| 153 | skeletal muscle contraction (GO:0003009) | 2.46836640 |
| 154 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.46599543 |
| 155 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.46202547 |
| 156 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.44766906 |
| 157 | negative regulation of cation channel activity (GO:2001258) | 2.43579072 |
| 158 | nucleobase catabolic process (GO:0046113) | 2.40674779 |
| 159 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.40450983 |
| 160 | cell communication by electrical coupling (GO:0010644) | 2.40362191 |
| 161 | neuron recognition (GO:0008038) | 2.38969560 |
| 162 | fatty acid transmembrane transport (GO:1902001) | 2.38498110 |
| 163 | response to inactivity (GO:0014854) | 2.37626058 |
| 164 | postsynaptic membrane organization (GO:0001941) | 2.35952053 |
| 165 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.35647363 |
| 166 | detection of calcium ion (GO:0005513) | 2.35049268 |
| 167 | membrane depolarization during action potential (GO:0086010) | 2.33839935 |
| 168 | regulation of synapse structural plasticity (GO:0051823) | 2.33287166 |
| 169 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.32744418 |
| 170 | regulation of sequestering of triglyceride (GO:0010889) | 2.31529129 |
| 171 | brown fat cell differentiation (GO:0050873) | 2.31493406 |
| 172 | response to muscle activity (GO:0014850) | 2.31215005 |
| 173 | potassium ion export (GO:0071435) | 2.30214758 |
| 174 | positive regulation of sodium ion transport (GO:0010765) | 2.28202899 |
| 175 | actin filament-based movement (GO:0030048) | 2.25512872 |
| 176 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.25019344 |
| 177 | skeletal muscle fiber development (GO:0048741) | 2.24015275 |
| 178 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.23921689 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.50403492 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.75050811 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.67615368 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.56386149 |
| 5 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 3.37074147 |
| 6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.23383989 |
| 7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.14871015 |
| 8 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 3.09141862 |
| 9 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.05621521 |
| 10 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.99466801 |
| 11 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.93633049 |
| 12 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.83333807 |
| 13 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.78274689 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.69241363 |
| 15 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.65057747 |
| 16 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.63475305 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.61890400 |
| 18 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.55087003 |
| 19 | GATA1_22025678_ChIP-Seq_K562_Human | 2.52755316 |
| 20 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.50361819 |
| 21 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.47751998 |
| 22 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.42673672 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.42435286 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.40766709 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.35290023 |
| 26 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.32990622 |
| 27 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.28326551 |
| 28 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.26043676 |
| 29 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.21862298 |
| 30 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.16180792 |
| 31 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.14989426 |
| 32 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.13185301 |
| 33 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.11438513 |
| 34 | CTCF_27219007_Chip-Seq_Bcells_Human | 2.08499761 |
| 35 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.07934170 |
| 36 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.03359561 |
| 37 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.02080138 |
| 38 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.00318105 |
| 39 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.00121318 |
| 40 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.96803183 |
| 41 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.96745639 |
| 42 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.96687443 |
| 43 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.96183602 |
| 44 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.94570115 |
| 45 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.94250726 |
| 46 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.94249917 |
| 47 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.93061687 |
| 48 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.86892420 |
| 49 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.85039801 |
| 50 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.83480981 |
| 51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.83222703 |
| 52 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.82852099 |
| 53 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.82686313 |
| 54 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.81442383 |
| 55 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.80988957 |
| 56 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.80205093 |
| 57 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.77706540 |
| 58 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.77706540 |
| 59 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.77266344 |
| 60 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.76159010 |
| 61 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.75986097 |
| 62 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.73272331 |
| 63 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.73043879 |
| 64 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.72827057 |
| 65 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.71620065 |
| 66 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.69879314 |
| 67 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.69343689 |
| 68 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.69141934 |
| 69 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.68706102 |
| 70 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.67596944 |
| 71 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.67571678 |
| 72 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.67205210 |
| 73 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.62102700 |
| 74 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.60892753 |
| 75 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.60696783 |
| 76 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.57088802 |
| 77 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.56424540 |
| 78 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.56293798 |
| 79 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.55251036 |
| 80 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.55210716 |
| 81 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.53026191 |
| 82 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.52462555 |
| 83 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.51563130 |
| 84 | P68_20966046_ChIP-Seq_HELA_Human | 1.51210820 |
| 85 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.49688575 |
| 86 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.49402566 |
| 87 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46592442 |
| 88 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.43813206 |
| 89 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.43726195 |
| 90 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.40299020 |
| 91 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.40171899 |
| 92 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.38616743 |
| 93 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.36143289 |
| 94 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.35726240 |
| 95 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.33971123 |
| 96 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.33088636 |
| 97 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31346721 |
| 98 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.31077796 |
| 99 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.29447481 |
| 100 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.29230612 |
| 101 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.28738547 |
| 102 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.28136178 |
| 103 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.27586935 |
| 104 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.26411077 |
| 105 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.26369079 |
| 106 | SA1_27219007_Chip-Seq_Bcells_Human | 1.25065364 |
| 107 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.20224397 |
| 108 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19422390 |
| 109 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.19199890 |
| 110 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.18760482 |
| 111 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.18290121 |
| 112 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.17762321 |
| 113 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.16770651 |
| 114 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.16513569 |
| 115 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.16442681 |
| 116 | AR_20517297_ChIP-Seq_VCAP_Human | 1.15777124 |
| 117 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.15713246 |
| 118 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15393196 |
| 119 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.14450627 |
| 120 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.14323859 |
| 121 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.13476934 |
| 122 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.12256919 |
| 123 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.10317162 |
| 124 | KDM2B_26808549_Chip-Seq_K562_Human | 1.10127553 |
| 125 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.09714107 |
| 126 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.09111705 |
| 127 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.08488927 |
| 128 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.07907679 |
| 129 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.07205809 |
| 130 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.06834288 |
| 131 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.06801734 |
| 132 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.05826874 |
| 133 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.02516584 |
| 134 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.01377177 |
| 135 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.01000196 |
| 136 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.00715015 |
| 137 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.00595333 |
| 138 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00344594 |
| 139 | ERA_21632823_ChIP-Seq_H3396_Human | 0.99785016 |
| 140 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.99773777 |
| 141 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.99371904 |
| 142 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.99010487 |
| 143 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.98923748 |
| 144 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.98716849 |
| 145 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.98462531 |
| 146 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.98069276 |
| 147 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.97478804 |
| 148 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.96646318 |
| 149 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.96396944 |
| 150 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.95940473 |
| 151 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.95646777 |
| 152 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.95482091 |
| 153 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.94911897 |
| 154 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.94049992 |
| 155 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.94039690 |
| 156 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.93628090 |
| 157 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.93529080 |
| 158 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.92567910 |
| 159 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.91999645 |
| 160 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.91315197 |
| 161 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.90669845 |
| 162 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 0.90634017 |
| 163 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.90341666 |
| 164 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.89769158 |
| 165 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.89698994 |
| 166 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.89182109 |
| 167 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88700175 |
| 168 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.88243212 |
| 169 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.87956111 |
| 170 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.87832150 |
| 171 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.87483616 |
| 172 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.87439945 |
| 173 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.87161139 |
| 174 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.85363864 |
| 175 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.84773839 |
| 176 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.84647700 |
| 177 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.84468766 |
| 178 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.84263647 |
| 179 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.84212496 |
| 180 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.83470197 |
| 181 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.81488013 |
| 182 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.81339669 |
| 183 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.80791444 |
| 184 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.78726672 |
| 185 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.78167355 |
| 186 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.76697971 |
| 187 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.75323279 |
| 188 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.75060678 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 3.65439351 |
| 2 | MP0004147_increased_porphyrin_level | 3.61827895 |
| 3 | MP0009379_abnormal_foot_pigmentation | 3.35020911 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 3.04360960 |
| 5 | MP0006036_abnormal_mitochondrial_physio | 3.03560459 |
| 6 | MP0004084_abnormal_cardiac_muscle | 2.83517374 |
| 7 | MP0002653_abnormal_ependyma_morphology | 2.73490057 |
| 8 | MP0003646_muscle_fatigue | 2.65288650 |
| 9 | MP0003787_abnormal_imprinting | 2.59162505 |
| 10 | MP0004036_abnormal_muscle_relaxation | 2.40639617 |
| 11 | MP0000749_muscle_degeneration | 2.35146197 |
| 12 | MP0001986_abnormal_taste_sensitivity | 2.34889500 |
| 13 | MP0004215_abnormal_myocardial_fiber | 2.33949369 |
| 14 | MP0009697_abnormal_copulation | 2.33752398 |
| 15 | MP0000751_myopathy | 2.28852967 |
| 16 | MP0003122_maternal_imprinting | 2.14480952 |
| 17 | MP0003123_paternal_imprinting | 2.13376838 |
| 18 | MP0002822_catalepsy | 2.03684862 |
| 19 | MP0003879_abnormal_hair_cell | 1.99529534 |
| 20 | MP0001188_hyperpigmentation | 1.99410475 |
| 21 | MP0005330_cardiomyopathy | 1.98777362 |
| 22 | MP0006035_abnormal_mitochondrial_morpho | 1.92561261 |
| 23 | MP0005085_abnormal_gallbladder_physiolo | 1.88678244 |
| 24 | MP0000750_abnormal_muscle_regeneration | 1.88281286 |
| 25 | MP0004859_abnormal_synaptic_plasticity | 1.88173897 |
| 26 | MP0003186_abnormal_redox_activity | 1.87913086 |
| 27 | MP0003656_abnormal_erythrocyte_physiolo | 1.87378900 |
| 28 | MP0002396_abnormal_hematopoietic_system | 1.86195172 |
| 29 | MP0005423_abnormal_somatic_nervous | 1.72049938 |
| 30 | MP0004130_abnormal_muscle_cell | 1.71481915 |
| 31 | MP0004484_altered_response_of | 1.70348682 |
| 32 | MP0001764_abnormal_homeostasis | 1.67712740 |
| 33 | MP0005075_abnormal_melanosome_morpholog | 1.64082777 |
| 34 | MP0004808_abnormal_hematopoietic_stem | 1.56635333 |
| 35 | MP0008875_abnormal_xenobiotic_pharmacok | 1.56021860 |
| 36 | MP0004510_myositis | 1.54856474 |
| 37 | MP0005365_abnormal_bile_salt | 1.53173901 |
| 38 | MP0000778_abnormal_nervous_system | 1.49292063 |
| 39 | MP0002736_abnormal_nociception_after | 1.47067630 |
| 40 | MP0002009_preneoplasia | 1.46548057 |
| 41 | MP0003724_increased_susceptibility_to | 1.45682322 |
| 42 | MP0003191_abnormal_cellular_cholesterol | 1.42546460 |
| 43 | MP0004145_abnormal_muscle_electrophysio | 1.40564371 |
| 44 | MP0002972_abnormal_cardiac_muscle | 1.35569370 |
| 45 | MP0005385_cardiovascular_system_phenoty | 1.33437752 |
| 46 | MP0001544_abnormal_cardiovascular_syste | 1.33437752 |
| 47 | MP0000372_irregular_coat_pigmentation | 1.32022792 |
| 48 | MP0003121_genomic_imprinting | 1.31043830 |
| 49 | MP0003635_abnormal_synaptic_transmissio | 1.29739360 |
| 50 | MP0005409_darkened_coat_color | 1.28769072 |
| 51 | MP0005397_hematopoietic_system_phenotyp | 1.28699538 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.28699538 |
| 53 | MP0003011_delayed_dark_adaptation | 1.28469341 |
| 54 | MP0004085_abnormal_heartbeat | 1.27108108 |
| 55 | MP0001485_abnormal_pinna_reflex | 1.26517158 |
| 56 | MP0001905_abnormal_dopamine_level | 1.25384847 |
| 57 | MP0000759_abnormal_skeletal_muscle | 1.24376549 |
| 58 | MP0005646_abnormal_pituitary_gland | 1.23312775 |
| 59 | MP0001968_abnormal_touch/_nociception | 1.23282888 |
| 60 | MP0003828_pulmonary_edema | 1.20482553 |
| 61 | MP0002735_abnormal_chemical_nociception | 1.19862950 |
| 62 | MP0008775_abnormal_heart_ventricle | 1.19465996 |
| 63 | MP0002234_abnormal_pharynx_morphology | 1.18030045 |
| 64 | MP0000230_abnormal_systemic_arterial | 1.17859899 |
| 65 | MP0000747_muscle_weakness | 1.17325852 |
| 66 | MP0006276_abnormal_autonomic_nervous | 1.17279277 |
| 67 | MP0005671_abnormal_response_to | 1.17046660 |
| 68 | MP0005332_abnormal_amino_acid | 1.17012136 |
| 69 | MP0005165_increased_susceptibility_to | 1.15815515 |
| 70 | MP0001853_heart_inflammation | 1.15031043 |
| 71 | MP0001440_abnormal_grooming_behavior | 1.15012012 |
| 72 | MP0002733_abnormal_thermal_nociception | 1.14755983 |
| 73 | MP0009840_abnormal_foam_cell | 1.13903566 |
| 74 | MP0005620_abnormal_muscle_contractility | 1.13175131 |
| 75 | MP0005319_abnormal_enzyme/_coenzyme | 1.13085120 |
| 76 | MP0004858_abnormal_nervous_system | 1.12780282 |
| 77 | MP0002063_abnormal_learning/memory/cond | 1.11256873 |
| 78 | MP0002064_seizures | 1.11017087 |
| 79 | MP0008789_abnormal_olfactory_epithelium | 1.10817218 |
| 80 | MP0001529_abnormal_vocalization | 1.10730734 |
| 81 | MP0002572_abnormal_emotion/affect_behav | 1.09869694 |
| 82 | MP0004142_abnormal_muscle_tone | 1.09601835 |
| 83 | MP0005666_abnormal_adipose_tissue | 1.08073585 |
| 84 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.07990794 |
| 85 | MP0003137_abnormal_impulse_conducting | 1.07460096 |
| 86 | MP0001970_abnormal_pain_threshold | 1.06699020 |
| 87 | MP0005084_abnormal_gallbladder_morpholo | 1.06470363 |
| 88 | MP0005464_abnormal_platelet_physiology | 1.06108553 |
| 89 | MP0000955_abnormal_spinal_cord | 1.06072938 |
| 90 | MP0004233_abnormal_muscle_weight | 1.05450365 |
| 91 | MP0003880_abnormal_central_pattern | 1.05278929 |
| 92 | MP0005266_abnormal_metabolism | 1.04960260 |
| 93 | MP0000343_altered_response_to | 1.03689847 |
| 94 | MP0005636_abnormal_mineral_homeostasis | 1.01843618 |
| 95 | MP0002971_abnormal_brown_adipose | 1.01633576 |
| 96 | MP0003195_calcinosis | 1.01574382 |
| 97 | MP0002876_abnormal_thyroid_physiology | 1.01266614 |
| 98 | MP0004043_abnormal_pH_regulation | 1.00378876 |
| 99 | MP0005670_abnormal_white_adipose | 1.00219551 |
| 100 | MP0010329_abnormal_lipoprotein_level | 0.99850766 |
| 101 | MP0003221_abnormal_cardiomyocyte_apopto | 0.98671591 |
| 102 | MP0002734_abnormal_mechanical_nocicepti | 0.98362264 |
| 103 | MP0002106_abnormal_muscle_physiology | 0.98176199 |
| 104 | MP0006138_congestive_heart_failure | 0.98127487 |
| 105 | MP0002166_altered_tumor_susceptibility | 0.97265837 |
| 106 | MP0000026_abnormal_inner_ear | 0.96694322 |
| 107 | MP0009785_altered_susceptibility_to | 0.96278261 |
| 108 | MP0002139_abnormal_hepatobiliary_system | 0.95299958 |
| 109 | MP0002557_abnormal_social/conspecific_i | 0.94934567 |
| 110 | MP0003878_abnormal_ear_physiology | 0.94679299 |
| 111 | MP0005377_hearing/vestibular/ear_phenot | 0.94679299 |
| 112 | MP0010368_abnormal_lymphatic_system | 0.94538180 |
| 113 | MP0004185_abnormal_adipocyte_glucose | 0.94411459 |
| 114 | MP0005645_abnormal_hypothalamus_physiol | 0.93445044 |
| 115 | MP0003943_abnormal_hepatobiliary_system | 0.92794970 |
| 116 | MP0005535_abnormal_body_temperature | 0.90676035 |
| 117 | MP0002132_abnormal_respiratory_system | 0.89131965 |
| 118 | MP0005394_taste/olfaction_phenotype | 0.88923363 |
| 119 | MP0005499_abnormal_olfactory_system | 0.88923363 |
| 120 | MP0002269_muscular_atrophy | 0.88459072 |
| 121 | MP0004885_abnormal_endolymph | 0.85114890 |
| 122 | MP0006292_abnormal_olfactory_placode | 0.85071346 |
| 123 | MP0001486_abnormal_startle_reflex | 0.84565452 |
| 124 | MP0004270_analgesia | 0.83837067 |
| 125 | MP0002638_abnormal_pupillary_reflex | 0.83815882 |
| 126 | MP0009643_abnormal_urine_homeostasis | 0.82711081 |
| 127 | MP0005375_adipose_tissue_phenotype | 0.82675227 |
| 128 | MP0002752_abnormal_somatic_nervous | 0.82524685 |
| 129 | MP0002272_abnormal_nervous_system | 0.81230083 |
| 130 | MP0002118_abnormal_lipid_homeostasis | 0.80964695 |
| 131 | MP0005376_homeostasis/metabolism_phenot | 0.80866789 |
| 132 | MP0005369_muscle_phenotype | 0.80719176 |
| 133 | MP0002332_abnormal_exercise_endurance | 0.80505597 |
| 134 | MP0001765_abnormal_ion_homeostasis | 0.79986224 |
| 135 | MP0002882_abnormal_neuron_morphology | 0.79982245 |
| 136 | MP0010030_abnormal_orbit_morphology | 0.79897769 |
| 137 | MP0010630_abnormal_cardiac_muscle | 0.79534133 |
| 138 | MP0001963_abnormal_hearing_physiology | 0.79316771 |
| 139 | MP0002184_abnormal_innervation | 0.77768799 |
| 140 | MP0000049_abnormal_middle_ear | 0.77679834 |
| 141 | MP0003329_amyloid_beta_deposits | 0.77112096 |
| 142 | MP0009745_abnormal_behavioral_response | 0.76951857 |
| 143 | MP0004924_abnormal_behavior | 0.76949197 |
| 144 | MP0005386_behavior/neurological_phenoty | 0.76949197 |
| 145 | MP0005058_abnormal_lysosome_morphology | 0.76853172 |
| 146 | MP0003950_abnormal_plasma_membrane | 0.76340790 |
| 147 | MP0002067_abnormal_sensory_capabilities | 0.76088432 |
| 148 | MP0004087_abnormal_muscle_fiber | 0.75007763 |
| 149 | MP0008874_decreased_physiological_sensi | 0.73750209 |
| 150 | MP0002095_abnormal_skin_pigmentation | 0.72544921 |
| 151 | MP0001664_abnormal_digestion | 0.72378219 |
| 152 | MP0008469_abnormal_protein_level | 0.71813995 |
| 153 | MP0008872_abnormal_physiological_respon | 0.71748104 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 5.27395422 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.21540701 |
| 3 | Hepatic necrosis (HP:0002605) | 5.01580600 |
| 4 | Hepatocellular necrosis (HP:0001404) | 4.83631078 |
| 5 | Mitochondrial inheritance (HP:0001427) | 4.81870984 |
| 6 | Acute encephalopathy (HP:0006846) | 4.72709762 |
| 7 | Increased CSF lactate (HP:0002490) | 4.41153199 |
| 8 | Myokymia (HP:0002411) | 4.29026264 |
| 9 | Progressive macrocephaly (HP:0004481) | 4.28600288 |
| 10 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.92892537 |
| 11 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.92892537 |
| 12 | Lactic acidosis (HP:0003128) | 3.84103177 |
| 13 | Increased muscle lipid content (HP:0009058) | 3.80917513 |
| 14 | Muscle fiber inclusion bodies (HP:0100299) | 3.79859297 |
| 15 | Increased intramyocellular lipid droplets (HP:0012240) | 3.76519928 |
| 16 | Cerebral edema (HP:0002181) | 3.74010440 |
| 17 | Type 1 muscle fiber predominance (HP:0003803) | 3.63509891 |
| 18 | Nemaline bodies (HP:0003798) | 3.62852787 |
| 19 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.61832119 |
| 20 | Exercise intolerance (HP:0003546) | 3.60681668 |
| 21 | Polyphagia (HP:0002591) | 3.59494804 |
| 22 | Asymmetric septal hypertrophy (HP:0001670) | 3.54716058 |
| 23 | Lipid accumulation in hepatocytes (HP:0006561) | 3.29820098 |
| 24 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.23432099 |
| 25 | Dicarboxylic aciduria (HP:0003215) | 3.23432099 |
| 26 | Hyporeflexia of lower limbs (HP:0002600) | 3.22335361 |
| 27 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.18684896 |
| 28 | Respiratory failure (HP:0002878) | 3.16384503 |
| 29 | Myopathic facies (HP:0002058) | 3.12882418 |
| 30 | Abnormality of the calf musculature (HP:0001430) | 3.12498300 |
| 31 | Generalized aminoaciduria (HP:0002909) | 3.11605494 |
| 32 | Increased serum lactate (HP:0002151) | 3.09918306 |
| 33 | 3-Methylglutaconic aciduria (HP:0003535) | 3.03455003 |
| 34 | Increased hepatocellular lipid droplets (HP:0006565) | 3.02640885 |
| 35 | Syncope (HP:0001279) | 3.02060681 |
| 36 | Renal Fanconi syndrome (HP:0001994) | 2.99571464 |
| 37 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.98470876 |
| 38 | Muscle fiber splitting (HP:0003555) | 2.96072149 |
| 39 | Proximal tubulopathy (HP:0000114) | 2.89479749 |
| 40 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.88327263 |
| 41 | Abnormality of alanine metabolism (HP:0010916) | 2.88327263 |
| 42 | Hyperalaninemia (HP:0003348) | 2.88327263 |
| 43 | Hypothermia (HP:0002045) | 2.83935807 |
| 44 | Hypoglycemic coma (HP:0001325) | 2.83486695 |
| 45 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.82675998 |
| 46 | Left ventricular hypertrophy (HP:0001712) | 2.82172107 |
| 47 | Neuroendocrine neoplasm (HP:0100634) | 2.80768793 |
| 48 | Palpitations (HP:0001962) | 2.80682522 |
| 49 | Lethargy (HP:0001254) | 2.78348647 |
| 50 | Myotonia (HP:0002486) | 2.76060755 |
| 51 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.73884740 |
| 52 | Hyperthyroidism (HP:0000836) | 2.68638950 |
| 53 | EMG: myopathic abnormalities (HP:0003458) | 2.66569464 |
| 54 | Esophageal neoplasm (HP:0100751) | 2.65523972 |
| 55 | Neoplasm of head and neck (HP:0012288) | 2.65523972 |
| 56 | Rimmed vacuoles (HP:0003805) | 2.65371894 |
| 57 | Ketoacidosis (HP:0001993) | 2.63925640 |
| 58 | Leukodystrophy (HP:0002415) | 2.63555681 |
| 59 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.62676467 |
| 60 | Thrombocytosis (HP:0001894) | 2.61965001 |
| 61 | Pheochromocytoma (HP:0002666) | 2.60988168 |
| 62 | Abnormal eating behavior (HP:0100738) | 2.60273608 |
| 63 | Type I transferrin isoform profile (HP:0003642) | 2.56090797 |
| 64 | Abnormal number of erythroid precursors (HP:0012131) | 2.51439724 |
| 65 | Prolonged QT interval (HP:0001657) | 2.50761914 |
| 66 | Oligomenorrhea (HP:0000876) | 2.49951237 |
| 67 | Optic disc pallor (HP:0000543) | 2.49888164 |
| 68 | Myoglobinuria (HP:0002913) | 2.49580635 |
| 69 | Bulbar palsy (HP:0001283) | 2.49479328 |
| 70 | Abnormality of glycolysis (HP:0004366) | 2.47497931 |
| 71 | Increased serum pyruvate (HP:0003542) | 2.47497931 |
| 72 | Increased variability in muscle fiber diameter (HP:0003557) | 2.47052779 |
| 73 | Ragged-red muscle fibers (HP:0003200) | 2.45414542 |
| 74 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.44352544 |
| 75 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.39915565 |
| 76 | Abnormal EKG (HP:0003115) | 2.39842988 |
| 77 | Ketosis (HP:0001946) | 2.39256873 |
| 78 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.35437032 |
| 79 | Absent phalangeal crease (HP:0006109) | 2.32283166 |
| 80 | Double outlet right ventricle (HP:0001719) | 2.32203110 |
| 81 | Congenital malformation of the right heart (HP:0011723) | 2.32203110 |
| 82 | Aplastic anemia (HP:0001915) | 2.32059953 |
| 83 | Waddling gait (HP:0002515) | 2.31497589 |
| 84 | Distal lower limb muscle weakness (HP:0009053) | 2.29484272 |
| 85 | Reduced antithrombin III activity (HP:0001976) | 2.29028847 |
| 86 | Methylmalonic aciduria (HP:0012120) | 2.27225978 |
| 87 | Methylmalonic acidemia (HP:0002912) | 2.25366610 |
| 88 | Agitation (HP:0000713) | 2.24057560 |
| 89 | Lipoatrophy (HP:0100578) | 2.23810799 |
| 90 | Ventricular arrhythmia (HP:0004308) | 2.23366901 |
| 91 | Atrial fibrillation (HP:0005110) | 2.19696554 |
| 92 | Distal arthrogryposis (HP:0005684) | 2.19669420 |
| 93 | Vomiting (HP:0002013) | 2.19031727 |
| 94 | Respiratory difficulties (HP:0002880) | 2.18942726 |
| 95 | Calf muscle hypertrophy (HP:0008981) | 2.18831497 |
| 96 | Hyperglycinemia (HP:0002154) | 2.18535333 |
| 97 | Exertional dyspnea (HP:0002875) | 2.18110266 |
| 98 | Anomalous pulmonary venous return (HP:0010772) | 2.16258228 |
| 99 | Sudden death (HP:0001699) | 2.16038825 |
| 100 | Difficulty running (HP:0009046) | 2.14038618 |
| 101 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.13526973 |
| 102 | Abnormal atrioventricular conduction (HP:0005150) | 2.12842613 |
| 103 | Supraventricular tachycardia (HP:0004755) | 2.12425557 |
| 104 | Maternal diabetes (HP:0009800) | 2.11735543 |
| 105 | Ventricular fibrillation (HP:0001663) | 2.09518081 |
| 106 | Bundle branch block (HP:0011710) | 2.09420040 |
| 107 | CNS demyelination (HP:0007305) | 2.09187594 |
| 108 | Fetal akinesia sequence (HP:0001989) | 2.07427803 |
| 109 | Tinnitus (HP:0000360) | 2.07180982 |
| 110 | Primary atrial arrhythmia (HP:0001692) | 2.06781227 |
| 111 | Dilated cardiomyopathy (HP:0001644) | 2.06663576 |
| 112 | Hyperammonemia (HP:0001987) | 2.06074164 |
| 113 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.05110053 |
| 114 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.05110053 |
| 115 | Abnormal protein glycosylation (HP:0012346) | 2.05110053 |
| 116 | Abnormal glycosylation (HP:0012345) | 2.05110053 |
| 117 | Metabolic acidosis (HP:0001942) | 2.04679662 |
| 118 | Supraventricular arrhythmia (HP:0005115) | 2.01350620 |
| 119 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.99831923 |
| 120 | EMG: neuropathic changes (HP:0003445) | 1.98556486 |
| 121 | Rhabdomyolysis (HP:0003201) | 1.97817972 |
| 122 | Type II lissencephaly (HP:0007260) | 1.95315097 |
| 123 | Abnormal hemoglobin (HP:0011902) | 1.95270709 |
| 124 | Glycosuria (HP:0003076) | 1.93764295 |
| 125 | Abnormality of urine glucose concentration (HP:0011016) | 1.93764295 |
| 126 | Abnormal pupillary function (HP:0007686) | 1.93720068 |
| 127 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.92847483 |
| 128 | Exercise-induced muscle cramps (HP:0003710) | 1.89335268 |
| 129 | Exercise-induced myalgia (HP:0003738) | 1.89028786 |
| 130 | Emotional lability (HP:0000712) | 1.88095840 |
| 131 | Gowers sign (HP:0003391) | 1.88032797 |
| 132 | Heart block (HP:0012722) | 1.87831069 |
| 133 | Infantile muscular hypotonia (HP:0008947) | 1.86737135 |
| 134 | Neck muscle weakness (HP:0000467) | 1.86563558 |
| 135 | Cerebral palsy (HP:0100021) | 1.86179868 |
| 136 | Ventricular tachycardia (HP:0004756) | 1.85363416 |
| 137 | Inability to walk (HP:0002540) | 1.85305783 |
| 138 | Delayed CNS myelination (HP:0002188) | 1.81692402 |
| 139 | Abnormality of the pulmonary veins (HP:0011718) | 1.81218775 |
| 140 | Type 2 muscle fiber atrophy (HP:0003554) | 1.81095991 |
| 141 | Microvesicular hepatic steatosis (HP:0001414) | 1.81060965 |
| 142 | Muscle stiffness (HP:0003552) | 1.80479735 |
| 143 | Opisthotonus (HP:0002179) | 1.79536007 |
| 144 | Prolonged neonatal jaundice (HP:0006579) | 1.79073242 |
| 145 | Abnormality of renal resorption (HP:0011038) | 1.78254153 |
| 146 | Petechiae (HP:0000967) | 1.77445198 |
| 147 | Nausea (HP:0002018) | 1.76889700 |
| 148 | Nonprogressive disorder (HP:0003680) | 1.76628885 |
| 149 | Gliosis (HP:0002171) | 1.75635778 |
| 150 | Gait imbalance (HP:0002141) | 1.75522364 |
| 151 | Visual hallucinations (HP:0002367) | 1.74607611 |
| 152 | Failure to thrive in infancy (HP:0001531) | 1.73983317 |
| 153 | Systemic lupus erythematosus (HP:0002725) | 1.71471721 |
| 154 | Poor suck (HP:0002033) | 1.68053981 |
| 155 | Subaortic stenosis (HP:0001682) | 1.66425402 |
| 156 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.66425402 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K12 | 4.03202987 |
| 2 | BCKDK | 3.49054214 |
| 3 | MUSK | 3.26271648 |
| 4 | STK16 | 3.25205139 |
| 5 | MYLK | 2.91125842 |
| 6 | NME2 | 2.84341799 |
| 7 | PIK3CG | 2.75191878 |
| 8 | FLT3 | 2.60106622 |
| 9 | KIT | 2.47039112 |
| 10 | TIE1 | 2.20775139 |
| 11 | MARK1 | 2.12430131 |
| 12 | CDK19 | 2.08090262 |
| 13 | PINK1 | 2.04637595 |
| 14 | ABL2 | 1.92661020 |
| 15 | GRK7 | 1.89754111 |
| 16 | KDR | 1.88970326 |
| 17 | EPHB2 | 1.80848721 |
| 18 | PDK2 | 1.79459860 |
| 19 | SIK3 | 1.79072041 |
| 20 | LIMK1 | 1.77882776 |
| 21 | DMPK | 1.72274413 |
| 22 | ARAF | 1.70833841 |
| 23 | INSRR | 1.69595258 |
| 24 | PIM2 | 1.66530220 |
| 25 | CASK | 1.66483336 |
| 26 | MAP2K3 | 1.59444548 |
| 27 | DYRK1B | 1.57233870 |
| 28 | MAP3K9 | 1.55786303 |
| 29 | VRK1 | 1.51594154 |
| 30 | ADRBK2 | 1.51312025 |
| 31 | MARK2 | 1.49108619 |
| 32 | MAP2K7 | 1.46912692 |
| 33 | DYRK2 | 1.46095571 |
| 34 | NTRK3 | 1.43068756 |
| 35 | DAPK1 | 1.39610640 |
| 36 | TNIK | 1.39041417 |
| 37 | TEC | 1.38172451 |
| 38 | PAK3 | 1.36769863 |
| 39 | TESK1 | 1.36122926 |
| 40 | TXK | 1.35349349 |
| 41 | PRKD3 | 1.35258632 |
| 42 | PDK4 | 1.31700854 |
| 43 | PDK3 | 1.31700854 |
| 44 | ERN1 | 1.28234492 |
| 45 | MAPK15 | 1.28222263 |
| 46 | MAPKAPK5 | 1.22811549 |
| 47 | CCNB1 | 1.21761164 |
| 48 | EPHA4 | 1.19923307 |
| 49 | TGFBR2 | 1.18174667 |
| 50 | MATK | 1.16823214 |
| 51 | PRKD2 | 1.16565311 |
| 52 | MAPKAPK3 | 1.15112829 |
| 53 | TGFBR1 | 1.14625021 |
| 54 | VRK2 | 1.14452497 |
| 55 | MAP4K1 | 1.12927957 |
| 56 | GRK5 | 1.10201120 |
| 57 | BTK | 1.09422149 |
| 58 | MAPK13 | 1.09407181 |
| 59 | WEE1 | 1.05949083 |
| 60 | PRKG2 | 1.04640803 |
| 61 | TSSK6 | 1.04596184 |
| 62 | MAP2K6 | 1.02185880 |
| 63 | CSF1R | 0.97277800 |
| 64 | RIPK4 | 0.97025503 |
| 65 | NLK | 0.94774770 |
| 66 | TESK2 | 0.94278438 |
| 67 | PKN1 | 0.91630176 |
| 68 | PHKG1 | 0.91529518 |
| 69 | PHKG2 | 0.91529518 |
| 70 | RPS6KA2 | 0.91096677 |
| 71 | CAMK1 | 0.89550619 |
| 72 | SYK | 0.88431628 |
| 73 | CDK8 | 0.86534681 |
| 74 | ZAP70 | 0.86219987 |
| 75 | PRKCG | 0.84503457 |
| 76 | DYRK3 | 0.84171405 |
| 77 | MAPK12 | 0.83518867 |
| 78 | PIK3CA | 0.82417939 |
| 79 | PRKD1 | 0.81865211 |
| 80 | NME1 | 0.80561066 |
| 81 | NTRK2 | 0.80204672 |
| 82 | STK11 | 0.79927468 |
| 83 | MAP2K4 | 0.79347883 |
| 84 | LMTK2 | 0.77330152 |
| 85 | DDR2 | 0.73610926 |
| 86 | MAP3K11 | 0.73492647 |
| 87 | IRAK4 | 0.72515735 |
| 88 | GRK1 | 0.71566520 |
| 89 | MAPK7 | 0.70378136 |
| 90 | LRRK2 | 0.70117683 |
| 91 | OBSCN | 0.70113572 |
| 92 | BRAF | 0.69436014 |
| 93 | JAK3 | 0.69164959 |
| 94 | TNK2 | 0.68752043 |
| 95 | TRIB3 | 0.68539606 |
| 96 | CAMKK2 | 0.67556920 |
| 97 | TTN | 0.67543948 |
| 98 | PRKCH | 0.67084306 |
| 99 | CAMK2B | 0.66515856 |
| 100 | STK24 | 0.63127971 |
| 101 | PRKCZ | 0.62219626 |
| 102 | CDK5 | 0.62054458 |
| 103 | PAK6 | 0.61901985 |
| 104 | CSNK1G2 | 0.60530654 |
| 105 | PRKAA1 | 0.59962462 |
| 106 | MAPK4 | 0.58638451 |
| 107 | TAOK1 | 0.57425527 |
| 108 | ILK | 0.56774529 |
| 109 | MAP3K7 | 0.56036183 |
| 110 | CAMK4 | 0.54337673 |
| 111 | RPS6KL1 | 0.53711358 |
| 112 | RPS6KC1 | 0.53711358 |
| 113 | SGK494 | 0.53652401 |
| 114 | SGK223 | 0.53652401 |
| 115 | MOS | 0.53644627 |
| 116 | DYRK1A | 0.53061199 |
| 117 | ICK | 0.52915985 |
| 118 | MINK1 | 0.52398798 |
| 119 | CAMKK1 | 0.51854010 |
| 120 | DAPK2 | 0.50736187 |
| 121 | CAMK2D | 0.50584178 |
| 122 | CSNK1G3 | 0.50025883 |
| 123 | MKNK2 | 0.49730579 |
| 124 | PTK2B | 0.48822881 |
| 125 | PRKCD | 0.48173615 |
| 126 | PDPK1 | 0.47702813 |
| 127 | TBK1 | 0.47624910 |
| 128 | RPS6KA6 | 0.47523589 |
| 129 | LCK | 0.46900618 |
| 130 | MAP3K6 | 0.46643949 |
| 131 | PKN2 | 0.45389222 |
| 132 | ADRBK1 | 0.45007797 |
| 133 | ROCK1 | 0.44058059 |
| 134 | PRKCE | 0.42628012 |
| 135 | PRKCA | 0.42071388 |
| 136 | RAF1 | 0.41983247 |
| 137 | MKNK1 | 0.41642550 |
| 138 | DAPK3 | 0.41088186 |
| 139 | CAMK2A | 0.40901334 |
| 140 | TRPM7 | 0.40357481 |
| 141 | LYN | 0.39464085 |
| 142 | FES | 0.39337852 |
| 143 | CAMK2G | 0.39143211 |
| 144 | BMPR1B | 0.38351762 |
| 145 | PRKAA2 | 0.37021368 |
| 146 | WNK3 | 0.36866767 |
| 147 | PRKACA | 0.36656892 |
| 148 | IKBKE | 0.33675612 |
| 149 | MAPK11 | 0.31440881 |
| 150 | YES1 | 0.30494967 |
| 151 | TYK2 | 0.30191001 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.32771799 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.22057822 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 3.95178161 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.11969630 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 2.89143978 |
| 6 | Alzheimers disease_Homo sapiens_hsa05010 | 2.83624456 |
| 7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.69834413 |
| 8 | Huntingtons disease_Homo sapiens_hsa05016 | 2.56262522 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.48863108 |
| 10 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.35249325 |
| 11 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.35248568 |
| 12 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.32227095 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.21465606 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.20056332 |
| 15 | Proteasome_Homo sapiens_hsa03050 | 2.19333405 |
| 16 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.17197524 |
| 17 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.94862918 |
| 18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.92841755 |
| 19 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.92310099 |
| 20 | Carbon metabolism_Homo sapiens_hsa01200 | 1.81712673 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 1.74814544 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.72278528 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.55156937 |
| 24 | Protein export_Homo sapiens_hsa03060 | 1.52460986 |
| 25 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.52176782 |
| 26 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.51736091 |
| 27 | RNA polymerase_Homo sapiens_hsa03020 | 1.50763474 |
| 28 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.37630567 |
| 29 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.34655167 |
| 30 | DNA replication_Homo sapiens_hsa03030 | 1.32145472 |
| 31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.31632485 |
| 32 | Sulfur relay system_Homo sapiens_hsa04122 | 1.25623633 |
| 33 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.24561017 |
| 34 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.22705590 |
| 35 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.22618104 |
| 36 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.21995339 |
| 37 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.16591682 |
| 38 | Insulin secretion_Homo sapiens_hsa04911 | 1.15247346 |
| 39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.09728735 |
| 40 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.08271084 |
| 41 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.07743428 |
| 42 | Metabolic pathways_Homo sapiens_hsa01100 | 0.99052506 |
| 43 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.98614424 |
| 44 | Mismatch repair_Homo sapiens_hsa03430 | 0.97953905 |
| 45 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.95516873 |
| 46 | Purine metabolism_Homo sapiens_hsa00230 | 0.92520519 |
| 47 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.89856961 |
| 48 | Cocaine addiction_Homo sapiens_hsa05030 | 0.88698309 |
| 49 | Retinol metabolism_Homo sapiens_hsa00830 | 0.88007888 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.87501354 |
| 51 | Nicotine addiction_Homo sapiens_hsa05033 | 0.86958984 |
| 52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.84752440 |
| 53 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.83065650 |
| 54 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.82443841 |
| 55 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.82428464 |
| 56 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.81660965 |
| 57 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.80814925 |
| 58 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.80367018 |
| 59 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.79126889 |
| 60 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.77487536 |
| 61 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.76181400 |
| 62 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.74811803 |
| 63 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.74670713 |
| 64 | Morphine addiction_Homo sapiens_hsa05032 | 0.71787722 |
| 65 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70428728 |
| 66 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.69678796 |
| 67 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.69597358 |
| 68 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.69496441 |
| 69 | GABAergic synapse_Homo sapiens_hsa04727 | 0.68238970 |
| 70 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.67349954 |
| 71 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.64093100 |
| 72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63932715 |
| 73 | Renin secretion_Homo sapiens_hsa04924 | 0.63693560 |
| 74 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.63088270 |
| 75 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.62556392 |
| 76 | Axon guidance_Homo sapiens_hsa04360 | 0.61938064 |
| 77 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.61367773 |
| 78 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60765542 |
| 79 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.60138217 |
| 80 | Galactose metabolism_Homo sapiens_hsa00052 | 0.59722957 |
| 81 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.59614993 |
| 82 | Other glycan degradation_Homo sapiens_hsa00511 | 0.59173990 |
| 83 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.56703054 |
| 84 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.56111884 |
| 85 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.55995627 |
| 86 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.55711482 |
| 87 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53947417 |
| 88 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.53320206 |
| 89 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.53224450 |
| 90 | Phototransduction_Homo sapiens_hsa04744 | 0.52407979 |
| 91 | Histidine metabolism_Homo sapiens_hsa00340 | 0.52403875 |
| 92 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.51955553 |
| 93 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.50927879 |
| 94 | Lysosome_Homo sapiens_hsa04142 | 0.50730421 |
| 95 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.50674043 |
| 96 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.49494364 |
| 97 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.49464330 |
| 98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48984204 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.47392790 |
| 100 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.46446683 |
| 101 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.46332553 |
| 102 | Taste transduction_Homo sapiens_hsa04742 | 0.45907219 |
| 103 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.44713875 |
| 104 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.44546071 |
| 105 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.36703114 |
| 106 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.36086180 |
| 107 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.35220371 |
| 108 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.33999195 |
| 109 | Olfactory transduction_Homo sapiens_hsa04740 | 0.32040115 |
| 110 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.29722917 |
| 111 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.29158814 |
| 112 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.27919307 |
| 113 | RNA degradation_Homo sapiens_hsa03018 | 0.26442324 |
| 114 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.26344080 |
| 115 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.26117772 |
| 116 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.25938218 |
| 117 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.24087852 |
| 118 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.22274232 |
| 119 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.21810888 |
| 120 | Circadian entrainment_Homo sapiens_hsa04713 | 0.20632174 |
| 121 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.20297220 |
| 122 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.17885048 |
| 123 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.17808186 |
| 124 | ABC transporters_Homo sapiens_hsa02010 | 0.17565343 |
| 125 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.16472218 |
| 126 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.15828378 |
| 127 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.15071098 |
| 128 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.13539057 |
| 129 | Salivary secretion_Homo sapiens_hsa04970 | 0.12987770 |
| 130 | Bile secretion_Homo sapiens_hsa04976 | 0.12714552 |
| 131 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.12601166 |
| 132 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.11813855 |
| 133 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.10674317 |

